EverBlu raided by AFP, page-73

https://www.copyright link/companie...creso-over-asic-trading-probe-20211125-p59c19

EverBlu Capital’s Adam Blumenthal will step down as chairman of Creso Pharma after the corporate regulator asked the company to produce documents linked to an investigation into suspected share trading contraventions.
“Creso Pharma appears to have become involved in the ASIC investigation because of common directorships between it and its corporate adviser, EverBlu Capital,” Creso said in a statement to the ASX, after halting its shares for two days.

No longer having Mr Blumenthal as chairman will allow the company to “distance” its operations and governance from the investigation, Creso said.
Mr Blumenthal, among the company’s largest investors with 10.3 per cent of the shares, will remain as a non-executive director after deciding to step down as chair. Federal police raided Mr Blumenthal’s office last week.
He told The Australian Financial Review, “I offered to step aside in the best interests of all stakeholders while this inquiry unfolded.”
The Australian Federal Police raided Mr Blumenthal’s office last week. Federal police, on behalf of the Australian Securities and Investments Commission (ASIC), also conducted raids in Brisbane and the Gold Coast linked to Tyson Scholz, another Creso shareholder.
Creso shares sank on news of the raids but the company initially denied any involvement. On Tuesday, it requested a two-day trading halt. On Thursday morning, the company said it had received a notice from ASIC, prompting a further 5 per cent fall in its shares to 9.5¢.....

......Other companies that have either had funds raised using EverBlu or promoted on social media by Mr Scholz have said they were not in contact with regulators.
YPB, a Perth-based business involved in anti-counterfeiting technology, and which had used EverBlu in raising capital, told the Financial Review it “has not received any queries from ASIC”.
Perth-based metals mining outfit TNG also said it had not been contacted by federal authorities. TNG had used EverBlu as a co-manager on a $12.5 million share placement earlier this month, but told investors it had “no ongoing commercial arrangements in place with EverBlu following completion of the share placement”.
Renergen, a South African-based helium hopeful, which had been promoted online, also confirmed it had “not been issued any notices from any regulatory body in connection with the matter”.